BPG is committed to discovery and dissemination of knowledge
Review
©2013 Baishideng Publishing Group Co.
World J Hepatol. Nov 27, 2013; 5(11): 603-611
Published online Nov 27, 2013. doi: 10.4254/wjh.v5.i11.603
Table 1 Risk stratification and need for cytomegalovirus prophylaxis
Donor CMV IgG statusRecipient CMV IgG statusRisk type1Need for CMV prophylaxis
PositivePositiveLow riskLow
PositiveNegativeHigh riskHigh
NegativePositiveLow riskLow
NegativeNegativeLow riskLow


Write to the Help Desk